Regel Therapeutics announces its participation at the Dravet Syndrome Conference and attendance at the European Dravet Syndrome Advanced Therapies Meeting in Madrid, Spain on March 23rd and 24th 2023.

March 16, 2023 San Francisco Biotechnology Network News News Comments Off on Regel Therapeutics announces its participation at the Dravet Syndrome Conference and attendance at the European Dravet Syndrome Advanced Therapies Meeting in Madrid, Spain on March 23rd and 24th 2023.

CAMBRIDGE, Mass. and BERKELEY, Calif., March 16, 2023 /PRNewswire/ -- Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to develop clinical products modulating gene expression, today announced that Jordane Dimidschstein, Ph.D., co-founder and COO,...

Click to view original post